Results 1 to 10 of about 8,968,837 (371)

Experiences of Patients With Rheumatic Diseases in the United States During Early Days of the COVID‐19 Pandemic

ACR Open Rheumatology, 2020
Objective Patients with rheumatic diseases such as rheumatoid arthritis (RA) and lupus have increased risk of infection and are treated with medications that may increase this risk yet are also hypothesized to help treat COVID‐19.
Kaleb Michaud, Kristin Wipfler, Yomei Shaw, Teresa A. Simon, Adam Cornish, Bryant R. England, Alexis Ogdie, Patricia Katz   +7 more
doaj   +2 more sources

Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study

Annals of the Rheumatic Diseases, 2021
Introduction Vaccination represents a cornerstone in mastering the COVID-19 pandemic. Data on immunogenicity and safety of messenger RNA (mRNA) vaccines in patients with autoimmune inflammatory rheumatic diseases (AIIRD) are limited.
V. Furer, T. Eviatar, D. Zisman, H. Peleg, D. Paran, D. Levartovsky, M. Zisapel, O. Elalouf, I. Kaufman, R. Meidan, A. Broyde, A. Polachek, J. Wollman, I. Litinsky, K. Meridor, H. Nochomovitz, Adi Silberman, D. Rosenberg, J. Feld, A. Haddad, Tal Gazzit, M. Elias, N. Higazi, F. Kharouf, G. Shefer, O. Sharon, S. Pel, S. Nevo, O. Elkayam   +28 more
semanticscholar   +1 more source

Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry

Annals of the Rheumatic Diseases, 2021
Objectives To determine factors associated with COVID-19-related death in people with rheumatic diseases. Methods Physician-reported registry of adults with rheumatic disease and confirmed or presumptive COVID-19 (from 24 March to 1 July 2020).
Anja Strangfeld, M. Schäfer, M. Gianfrancesco, S. Lawson-Tovey, J. Liew, L. Ljung, E. Mateus, C. Richez, M. Santos, G. Schmajuk, C. Scirè, E. Sirotich, J. Sparks, P. Sufka, T. Thomas, L. Trupin, Z. Wallace, Sarah Al-Adely, J. Bachiller-Corral, S. Bhana, P. Cacoub, L. Carmona, R. Costello, W. Costello, L. Gossec, R. Grainger, E. Hachulla, R. Hasseli, J. Hausmann, K. Hyrich, Z. Izadi, L. Jacobsohn, P. Katz, L. Kearsley‐Fleet, P. Robinson, J. Yazdany, P. Machado   +36 more
semanticscholar   +1 more source

Disease activity and humoral response in patients with inflammatory rheumatic diseases after two doses of the Pfizer mRNA vaccine against SARS-CoV-2

Annals of the Rheumatic Diseases, 2021
Background The registration trials of messenger RNA (mRNA) vaccines against SARS-CoV-2 did not address patients with inflammatory rheumatic diseases (IRD).
Y. Braun-Moscovici, M. Kaplan, Maya Braun, D. Markovits, S. Giryes, K. Toledano, Y. Tavor, K. Dolnikov, A. Balbir-Gurman   +8 more
semanticscholar   +1 more source

Towards Super-Resolution CEST MRI for Visualization of Small Structures [PDF]

Proceedings, German Workshop on Medical Image Computing (2022) 210-215, 2021
The onset of rheumatic diseases such as rheumatoid arthritis is typically subclinical, which results in challenging early detection of the disease. However, characteristic changes in the anatomy can be detected using imaging techniques such as MRI or CT.
arxiv   +1 more source

Safety and immunogenicity of inactivated COVID-19 vaccination in adult rheumatic patients in South China: a prospective study

Human Vaccines & Immunotherapeutics, 2022
Patients with rheumatic diseases (RD) are considered to be a high-risk population for infection with the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).
Huiqiong Zeng, Hanjiang Liu, Zhi Liu, Xiakai Zhou, Xiaoping Lu, Zhenbo Yan, Yan Zhou, Liping Dai, Yashuo Chen, Tingting Yang, Zhihua Yin, Zhizhong Ye   +11 more
doaj   +1 more source

Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey

RMD Open, 2021
Background We describe the early experiences of adults with systemic rheumatic disease who received the COVID-19 vaccine. Methods From 2 April to 30 April 2021, we conducted an online, international survey of adults with systemic rheumatic disease who ...
S. Sattui, J. Liew, K. Kennedy, E. Sirotich, M. Putman, Tarin T Moni, A. Akpabio, D. Alpízar-Rodríguez, F. Berenbaum, I. Buliņa, R. Conway, A. Singh, Eimear Duff, K. Durrant, T. Gheita, C. Hill, Richard A Howard, B. Hoyer, E. Hsieh, Lina El Kibbi, Adam Kilian, A. H. Kim, D. Liew, Chieh Lo, B. Miller, S. Mingolla, M. Nudel, C. Palmerlee, J. Singh, Namrata Singh, M. Ugarte-Gil, J. Wallace, Kristen J Young, S. Bhana, W. Costello, R. Grainger, P. Machado, P. Robinson, P. Sufka, Z. Wallace, J. Yazdany, Carly Harrison, M. Larché, M. Levine, G. Foster, L. Thabane, L. Rider, J. Hausmann, J. Simard, J. Sparks   +49 more
semanticscholar   +1 more source

LncRNA H19 induces immune dysregulation of BMMSCs, at least partly, by inhibiting IL-2 production

Molecular Medicine, 2021
Background Systemic lupus erythematosus (SLE) is a representative systemic autoimmune disease. LncRNA H19 has been identified to participate in various biological processes in human diseases. However, the role of H19 in SLE remains unclear.
Xinpeng Chen, Xiuxia Luo, Yazhi Wei, Hualin Sun, Liping Dai, Yidou Tangzhou, Huijie Jin, Zhihua Yin   +7 more
doaj   +1 more source

Low-Dose IL-2 Therapy in Autoimmune and Rheumatic Diseases

Frontiers in Immunology, 2021
Regulatory T cells (Treg) are crucial for the maintenance of peripheral tolerance and for the control of ongoing inflammation and autoimmunity. The cytokine interleukin-2 (IL-2) is essentially required for the growth and survival of Treg in the ...
H. Grasshoff, Sara Comdühr, Luisa R. Monne, A. Müller, P. Lamprecht, G. Riemekasten, J. Humrich   +6 more
semanticscholar   +1 more source

American College of Rheumatology Guidance for COVID‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 5

Arthritis & Rheumatology, 2022
To provide guidance to rheumatology providers on the use of COVID‐19 vaccines for patients with rheumatic and musculoskeletal diseases (RMDs).
J. Curtis, S. Johnson, Dona Anthony, R. Arasaratnam, L. Baden, A. Bass, C. Calabrese, E. Gravallese, R. Harpaz, Andrew T. Kroger, R. Sadun, Amy S. Turner, E. Williams, T. Mikuls   +13 more
semanticscholar   +1 more source